TheProfitWatch

ZBIO - Zenas BioPharma, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
35.53 0.59 (1.66%) 0.0 (0.0%) 0.09 (0.25%) 0.02 (0.06%) 0.0 (0.0%) 1.28 (3.67%) --- 0.0 (0.0%)

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-1.25
Diluted EPS:
-1.25
Basic P/E:
-28.896
Diluted P/E:
-28.896
RSI(14) 1m:
58.62
VWAP:
36.11
RVol:

Events

Period Kind Movement Occurred At

Related News